Hopes of finding an early-warning signal for ovarian cancer have been boosted by a protein discovery at the Hunter Medical Research Institute (HMRI).
A research team from the University of Newcastle and Hunter New England Health, comprising cancer scientists, oncologists, gynaecologists and geneticists, spent three years investigating the earliest lesions involved in the disease with the goal of developing a biomarker test.
As published in the international biology journal Development, they detected elevated levels of ‘Wnt’ proteins being secreted by ovarian lesions.
This signalling, in turn, regulates a stem cel…
Cancers – Healthcanal.com